An Assessment of H1N1 Influenza-Associated Acute Respiratory Distress Syndrome Severity after Adjustment for Treatment Characteristics by Riscili, Brent P. et al.
An Assessment of H1N1 Influenza-Associated Acute
Respiratory Distress Syndrome Severity after Adjustment
for Treatment Characteristics
Brent P. Riscili
1,3, Tyler B. Anderson
3, Hallie C. Prescott
3, Matthew C. Exline
1,3, Madhuri M. Sopirala
2,3,
Gary S. Phillips
4, Naeem A. Ali
1,3*
1The Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University Medical Center, Columbus, Ohio, United States of America, 2The Division
of Infectious Diseases, The Ohio State University Medical Center, Columbus, Ohio, United States of America, 3Department of Internal Medicine, The Ohio State University
Medical Center, Columbus, Ohio, United States of America, 4Center for Biostatistics, The Ohio State University Medical Center, Columbus, Ohio, United States of America
Abstract
Pandemic influenza caused significant increases in healthcare utilization across several continents including the use of high-
intensity rescue therapies like extracorporeal membrane oxygenation (ECMO) or high-frequency oscillatory ventilation
(HFOV). The severity of illness observed with pandemic influenza in 2009 strained healthcare resources. Because lung injury
in ARDS can be influenced by daily management and multiple organ failure, we performed a retrospective cohort study to
understand the severity of H1N1 associated ARDS after adjustment for treatment. Sixty subjects were identified in our
hospital with ARDS from ‘‘direct injury’’ within 24 hours of ICU admission over a three month period. Twenty-three subjects
(38.3%) were positive for H1N1 within 72 hours of hospitalization. These cases of H1N1-associated ARDS were compared to
non-H1N1 associated ARDS patients. Subjects with H1N1-associated ARDS were younger and more likely to have a higher
body mass index (BMI), present more rapidly and have worse oxygenation. Severity of illness (SOFA score) was directly
related to worse oxygenation. Management was similar between the two groups on the day of admission and subsequent
five days with respect to tidal volumes used, fluid balance and transfusion practices. There was, however, more frequent use
of ‘‘rescue’’ therapy like prone ventilation, HFOV or ECMO in H1N1 patients. First morning set tidal volumes and BMI were
significantly associated with increased severity of lung injury (Lung injury score, LIS) at presentation and over time while
prior prescription of statins was protective. After assessment of the effect of these co-interventions LIS was significantly
higher in H1N1 patients. Patients with pandemic influenza-associated ARDS had higher LIS both at presentation and over
the course of the first six days of treatment when compared to non-H1N1 associated ARDS controls. The difference in LIS
persisted over the duration of observation in patients with H1N1 possibly explaining the increased duration of mechanical
ventilation.
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Introduction
Pandemic influenza drove significant increases in healthcare
utilization across several continents in 2009.[1,2,3,4,5] Many of
these patients were critically ill with need for significant ventilatory
support, mechanical ventilation and even extracorporeal sup-
port.[6] In fact, despite the lack of systematic data available it has
been suggested that influenza associated ARDS, because of its
severity may be considered a preferred condition for extracorpo-
real support when severe.[7] Several other factors have been
observed in cases of H1N1 associated respiratory failure. Female
gender, obesity and younger age appear particularly over-
represented amongst those patients with H1N1.[4,8,9] In addition,
associated organ failure with shock and renal failure appeared to
be very common in these same patients.
Unfortunately, these factors can be associated with worsening of
hypoxemia or ARDS severity. Obesity’s effects on normal
pulmonary physiology may predispose to the development of
ALI, but also worsen its manifestation [10] although its effect on
outcome is controversial. [11] Separately, it is possible that
additional organ failures like shock and renal failure can
independently influence the severity of acute lung injury. Fluid
accumulation whether secondary to renal failure or fluid
resuscitation can worsen oxygenation and thus lung injury.[12]
In addition, other associated treatments like tidal volumes used
and transfusion practices could influence the severity or duration
of ALI in critically ill patients.[13,14] In fact, if the severity of
influenza associated acute lung injury is higher than typical
ARDS, the use of low-tidal volume ventilation may be abandoned
because of its adverse effects on oxygenation.[13]
As a result, we hypothesized that the severity of the acute
respiratory distress syndrome in H1N1 patients was at least partly
explained by patient or treatment characteristics. No prior studies
have directly compared H1N1- associated ARDS with contem-
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retrospective cohort analysis comparing patients with ARDS in
association with H1N1 or other non-H1N1 causes of direct lung
injury. We specifically included an assessment of patient
characteristics, ventilator strategies, transfusion and fluid balance
practices. The purpose of this study was to better understand the
interaction between associated treatments and ARDS severity in
order to put in context the importance H1N1 influenza as a
specific cause.
Methods
Objectives
We performed a retrospective analysis of prospectively identi-
fied patients with ARDS admitted to the Medical Intensive Care
Unit over a three month time period from October 1
st until
December 31
st, 2009 at The Ohio State University Medical
Center. The primary goal was to describe the severity of illness
over time in patients with H1N1 associated ARDS in order to
determine whether treatments for ARDS or associated organ
failure could explain the prolonged and intense course of critical
illness in these patients. We specifically hypothesized that
associated organ failure (like shock) would lead to specific
treatments (like transfusions) that would contribute to the severity
of ARDS.
Participants
From October 1
st until December 31
st, 2009, our ICU had
standardized protocols in place to obtain nasopharyngeal swabs
from all patients admitted to the ICU with respiratory failure to
screen for influenza. Patients requiring mechanical ventilation
were screened daily for hypoxemia consistent with acute lung
injury (PaO2/FiO2 ratio ,300) according to consensus crite-
ria.[15] Physician investigators then reviewed the case for
radiographic and clinical characteristics in order to confirm the
suspicion that hypoxemia was caused by ARDS (PaO2/FiO2 ratio
,200).[15] Subjects were only excluded from study if they were
younger than eighteen or a prisoner or ward of the state. To
minimize potential confounders associated with systemic infections
and trauma this cohort was confined to those subjects with
presumed ‘‘direct’’ lung injury.
Description of Procedures or Investigations undertaken
Cases were identified as being H1N1-associated if nasal swab or
respiratory secretions were positive for novel influenza A (H1N1)
by specific rapid antigen or culture testing. Non-H1N1 associated
cases were the remaining cases identified. H1N1 positive patients
without ARDS are not included.
Nasal swabs that were processed for confirmatory influenza
testing by polymerase chain reaction testing were confirmed by
panel (xTAG) or specific influenza A and B PCR (Luminex
Molecular Diagnostics, Toronto, CA).[16] Positive tests were
confirmed as being caused by H1N1 using the Prodesse ProFlu-
ST, Influenza A [2009] real-time PCR (H1N1 subtyping) assay
(Focus Diagnostics, Cypress, CA). Not all samples were processed
for PCR confirmation. However, in our central lab all samples
processed clinically or automatically after random selection (n=10
per month in non-subtyped samples) were 2009 H1N1 positive
during the observation period.
After identifying patients as having ARDS, charts were
reviewed for demographic and severity of illness information.
Special attention was paid to identifying the duration of symptoms,
clinical factors and treatments delivered over the first six days of
mechanical ventilation. The six days of follow-up was based on our
prior experience of the median duration of mechanical ventilation
in our institution and a concern that after this point hypoxemia
would be confounded by too many other variables to allow
interpretation. This was collected from admitting histories or
notes. Specifically, the daily ventilator settings, pulmonary
compliance and oxygenation parameters were recorded from first
available values after eight am each morning. In addition, fluid
balance, transfusions and the presence of shock were recorded on
a daily basis. ARDS severity was primarily measured as the lung
injury (Murray) score.[17]
Cohort demographics, co-morbidities and cause of ARDS were
collected by manual chart review. Medical history was catego-
rized according to notation in the admitting history available for
all patients at the time of the ICU admission. Cause of ARDS
was obtained from information available in the same admitting
history. Severity of illness was calculated as the SOFA score
[18,19] and ARDS severity as PaO2:FiO2 ratio and the lung
injury (Murray) score.[17] To allow the comparison of LIS
between groups with different durations of ventilator use, we also
present LIS as an area under the curve (AUC) per day of
measurement where specified. Covariates collected over the first
6 days of ventilator care were the following: highest tidal volume
used for at least one hour during the observation day, net fluid
balance, transfusion of any blood product, time to antiviral
therapy, shock and vasopressor use.
Ethics
Review of these records and the performance of this study were
approved in advance by our local human subject’s protection
committee. (2009E0979) The Ohio State University Medical
Center’s human subjects Institutional Review Board approved this
research as not needing informed consent as all data was collected
without identifying PHI and analyzed anonymously.
Statistical Methods
Cohort characteristics were quantified and compared using
Student’s t-test or Wilcoxon rank sum test for all quantitative
measures depending on the normality of the data. Dichotomous
variables were assessed for significant difference using the
Pearson’s chi-square statistic or Fisher’s exact test. For analysis
of the factors associated with ARDS severity over time, random-
effects maximum likelihood linear regression was used with H1N1
status as the primary risk factor. Random-effects regression was
used since observations were nested within subject over time, thus
the within and between subject variability was used to estimate the
standard errors used to test the model coefficients. Baseline and
treatment related covariates were then added into the model
individually and any variable changing the risk factor coefficient
by 615% was included in the final adjusted analysis. Variables
specifically tested included, gender, BMI, age, race, transfusion
days, net fluid balance, vasopressor use and cause of lung injury.
Results
Eighty-two patients (17.4% of total) were admitted to the
medical ICU with a diagnosis of ARDS. (Figure 1) Of 60 patients
with direct lung injury, 23 (38.3%) had influenza-associated
disease (14/23 or 60.8% confirmed H1N1 by PCR) although all
tested cases presenting to our institution from September 2009
through April 2010 were found to be H1N1. Similar to other prior
reports, subjects with H1N1-associated ARDS were slightly
younger, with a larger body mass index. Additionally, these
subjects were more likely to receive mechanical ventilation sooner
after the onset of symptoms. (Table 1)
H1N1 Influenza Associated ARDS Severity
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higher severity of illness and worse oxygenation at presentation
when compared to other ARDS patients. (Table 1) Although there
was slightly more hypotension as measured by the SOFA
cardiovascular sub score over the days of observation (Table 2)
there were no significant differences in shock or vasopressor
requirement over the first six days. In addition, there were no
significant differences in tidal volumes or fluid balance over the
observation period. (Table 2) However, there was a trend toward a
higher frequency of transfusion over the course of the first six days
of treatment that did not reach a statistically significant level.
(Table 2) Oseltamivir was administered to all H1N1 subjects at a
dose of 150 mg twice daily within 2 days of the onset of ILI
symptoms except one patient who had renal failure and received
75 mg BID. A further two subjects received this level after two
days of 75 mg twice daily.
The level of positive end-expiratory pressure appeared to be
higher in patients with H1N1-associated ARDS in keeping with its
associated worsened hypoxemia. (Figure 2 and Table 1) Consistent
with prior observations, there was also more frequent use of rescue
therapies like extracorporeal membrane oxygenation or high
frequency oscillatory ventilation in H1N1-associated ARDS,
although these interventions were not protocolized and therefore
cannot directly reflect acuity. (Table 2)
Lung injury scores (LIS) were significantly worse in patients with
H1N1-associated ARDS. (Table 3) Assessment of variables
associated with lung injury severity revealed that variables that
significantly changed the relationship between H1N1 status and
LIS were BMI, evidence of statin use at the time of admission and
daily tidal volume delivered. Tidal volume and BMI were directly
related and significantly associated with a worsening of lung injury;
whereas, statin use was associated with lower LIS. After
adjustment for each of these factors, both the daily and total
AUC for LIS was significantly higher in patients with H1N1
associated disease. (Table 4) Adjustment for transfusions, fluid
balance or shock treatment had no direct influence on the
relationship between LIS and H1N1 status. In addition, there was
no evidence of association between time to influenza virus-active
antiviral administration (Oseltamivir) in patients with H1N1 and
severity of LIS at presentation or AUC LIS.
Discussion
We present the first cohort study that directly compares the
severity of H1N1-associated ARDS to a contemporaneous cohort
of non influenza associated ARDS. The use of ARDS control
subjects and the depth and breadth of co-interventions described
make this analysis unique. Our data quantitatively confirm what
was suggested by observational cohort studies in clinical
practice.[2,3,4] By using a very specific control group and
including a rigorous collection of treatment practices, we can be
more confident in our conclusion that the severity of H1N1
associated ARDS was higher than non-H1N1 associated lung
injury. As such, it may justify a designation as a unique phenotype
of ARDS that warrants specific description.
Several observations are interesting in this cohort. First of all,
despite the impression of multiple organ failure in H1N1-
associated illness, the severity of illness at presentation in H1N1
Figure 1. Cohort enrollment diagram.
doi:10.1371/journal.pone.0018166.g001
H1N1 Influenza Associated ARDS Severity
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e18166associated patients was largely driven by more severe hypoxemia.
Additionally, this difference in severity of lung injury appears to
extend for several days beyond presentation. This is supported by
several pathologic or autopsy studies that have demonstrated very
severe diffuse alveolar damage in H1N1 patients.[20,21] Because
of the collection of interventions, our data suggests that it is
unlikely that treatment-related lung injury played a role in
propagating hypoxemia as tidal volumes and other practices were
similar in both treatment groups. Therefore, the severity of
pulmonary injury is not likely related to co-interventions, but the
direct virulence of the pathogen or immune response of the
host.[22,23] The data from this study can be reasonably used to
suggest that institutions should develop well-defined approaches to
care for severe influenza associated ARDS patients, because of the
severity of hypoxemia at onset. In addition, the duration of critical
illness and severity of hypoxemia confirmed in our cohort in
comparison to more ‘‘routine’’ ARDS confirms that any allocated
resources will be utilized for significant periods of time.
The second observation of interest is that when compared to
contemporaneous control ARDS patients, the severity of non-
pulmonary organ failure was no worse in H1N1-associated
disease. In fact, there were no major differences in any non-
pulmonary organ failures between the two groups. One organ
failure that is very relevant to the management of refractory
ARDS is shock. The presence of shock could prevent the use of
conservative fluid management strategy which reduces hypoxemia
and ventilator use or make the use of ‘‘rescue’’ therapies like prone
ventilation or HFOV more difficult. However, while there were
numerically small increases in the days of vasopressor use,
transfusions and net fluid balance on days without hypotension
Table 1. Baseline characteristics of the ARDS cohort with direct lung injury.
H1N1-associated
ARDS (n=23)
Non H1N1- associated
ARDS (n=37)
Total cohort
(n=60) p-value
1
Age, years 42.5616.25 50.9626.7 47.7623.5 0.177
Male (%) 51.4 47.8 50.0 .0.99
BMI, median (IQR) 35.2 (27.5–50.8) 30.7 (24.0–36.6) 32.3 (25.1–41.8) 0.064
Pregnancy, n (% of females) 2 (16.7) 0 (0) 2 (6.7) 0.152
Caucasian (%) 73.9 70.3 71.7 .0.99
Hispanic (%) 34.8 24.3 28.3 0.396
Medical History, n (%)
N Asthma 2 (8.7) 4 (10.8) 6 (10.0) .0.99
N COPD 1 (4.4) 8 (21.6) 9 (15.0) 0.134
N Cancer history 1 (4.4) 8 (21.6) 9 (15.0) 0.134
N DM 4 (17.4) 7 (18.9) 11 (18.3) .0.99
N Immunocompromised condition 2 (8.7) 5 (13.5) 7 (11.7) 0.697
Tobacco use, n (%) 7 (30.4) 9 (24.3) 16 (26.7) 0.60
Prior statin use, n (%) 3 (13.0) 13 (35.1) 16 (26.7) 0.06
Influenza testing
N Nasopharyngeal swab, n (%) 15/24 (62.5) 0/54 (0.0)
N Bronchoalveolar lavage fluid, n (%) 10/11 (90.1) NR
Duration of symptoms before
hospitalization (hrs), median (IQR)
72 (48–168) 72 (24–120) 72 (36–156) 0.407
Time until need for mechanical
ventilation (hrs), median (IQR)
0 (0–0) 0 (0–1) 0 (0–0) 0.084
Shock (%) 56.5 56.8 56.7 .0.99
Cardiovascular failure, median (IQR)
N Days of pressor use through day 3 2 (0–3) 1 (0–3) 1 (0–2) 0.126
N Days of pressor use through Day 6 2 (0–3) 1 (0–3) 1 (0–3) 0.197
N Average CV SOFA score through Day 3 3 (1–4) 1.7 (0.3–3) 1.7 (0.7–3.3) 0.060
N Average CV SOFA score through day 6 2.0 (0.5–3.2) 1.7 (0.3–2.8) 1.7 (0.4–3) 0.197
CXR score (0–4 quadrants with
infiltrates) through day 6, median (IQR)
4 (4–4) 4 (3–4) 4 (4–4) 0.003
SOFA score through day 6 11.964.7 9.565.5 10.565.3 0.002
SOFA (no respiratory subscore) through day 6 8.564.4 6.965.0 7.664.8 0.006
PaO2:FiO2 through day 6, median (IQR) 101.5 (65–134) 148 (95–190) 119 (74–170) ,0.001
Lung Injury (Murray) Score, median (IQR) 3.5 (3.0–3.8) 2.8 (2.5–3.3) 3 (2.5–3.5) ,0.001
All values represent means 6 SD unless otherwise specified.
1p-values based on the following tests: t-test for variables presented as means, Wilcoxon rank-sum test for variables presented as the median, Fisher’s exact test of
association for categorical variables.
doi:10.1371/journal.pone.0018166.t001
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severity of lung injury in our analysis. The finding of equivalent
non-pulmonary organ failure could be related to the small size of
our cohort or how severely ill our control ARDS subjects were. In
fact, 57.1% of our non-H1N1 ARDS patients had evidence of
shock at presentation, whereas only ,32% of patients in published
series have this significant organ failure.[12,24] Our analysis
suggests that this organ failure is likely no more common than in
other patients with ARDS and is simply part of ‘‘expected’’
multiple organ failure. However, our cohort of non-H1N1 ARDS
patients may be particularly ill.
Limitations
There are several limitations to our study. First, our sample is
relatively small and derived from a single center. It is possible that
single center management can be confounded by unmeasured co-
interventions and variation in practice. To counteract this effect,
we have gone to great lengths to collect treatment variables that
are likely to impact overall oxygenation in ARDS patients. Tidal
volumes and fluid management strategies are both known to
influence oxygenation [12,13] in ARDS patients and transfusions
to influence its development. [14] It was our aim to include these
variables to limit the number of potential unmeasured covariates
which would effect our conclusions. Another difference in our
study is the use of lung injury score to measure severity of ARDS.
The use of the lung injury score as a measure of ARDS severity is
not routine. This was chosen primarily, because it has been
suggested as a tool to identify patients who may need rescue
therapy,[17] but also because it assesses more than simply
oxygenation. As such it could have been more sensitive to changes
other than hypoxemia. As a result, we are more assured that our
finding that the difference in severity of illness is related to simply
worsened gas exchange impairment is true. However, similar
trends in severity were seen in PaO2/FiO2 ratio and ventilator
use. Still it would have been informative to collect data on other
variables like oxygenation index. Additionally, it is possible that
our findings are confounded by the relatively narrow range of
management for these patients. Our conventional ventilator
management is protocolized and may prevent the detection of
greater effects in other units with a wider variation in practice.
Table 2. Treatment variables over the first six days of therapy and outcomes.
H1N1-associated
ARDS (n=23)
Non-H1N1 associated
ARDS (n=37)
Total cohort
(n=60) p-value
1
Tidal Volume
(ml/kg PBW), median (IQR)
N Day 1 6.1 (6.0–6.8) 6.5 (6.5–6.8) 6.5 (6.0–7.2) 0.789
N Day 3 5.7 (5.7–6.1) 6.0 (6.0–6.2) 6.1 (6.0–6.8) 0.309
N Average over first 6 days 5.9 (5.9–6.0) 6.4 (6.1–6.5) 6.3 (6.0–6.5) ,0.001
Transfusions
N Prior to ICU admit (%) 34.8 21.6 26.7 0.369
N Any transfusion to Day 6 (%) 56.5 43.2 48.3 0.427
N Days with any transfusion to Day 6, median (IQR) 1 (0–3) 0 (0–2) 1 (0–2) ,0.001
N Proportion of first 6 ICU days with transfusion, median (IQR) 20 (0–60) 0 (0–50) 0 (0–50) 0.390
Vasopressor use
N Total days of therapy, median (IQR) 2 (0–5) 1 (0–4) 2 (0–5) 0.411
N To Day 3, (%) 65.2 59.5 61.7 0.787
Net fluid balance (mean, 6SD)
N to Day 6 9,07568,070 8,06368,684 8,45168,399 0.654
N On days with MAP.70 only 1,85564,184 1,33263,768 1,55263,888 0.718
ECMO use (%) 17.4 0.0 6.7 0.018
HFOV use (%) 26.1 5.4 13.3 0.045
Antiviral therapy
N Antiviral therapy initiated (%) 23 (100.0)
N Days from hospital admit until treatment, median (IQR) 0 (0–1)
ICU length of stay (d), median (IQR) 20 (9–31) 11 (6–17) 15 (7–23) ,0.001
Ventilator days, median (IQR) 20 (8–31) 10 (4–16) 12.5 (6–21) ,0.001
Ventilator-free days to day 30, median (IQR) 0 (0–17) 7 (0–26) 0 (0–23) ,0.001
Hospital length of stay (d), median (IQR) 25 (14–33) 18 (12–24) 20 (12–29) ,0.001
Hospital free days to day 60 (d), median (IQR) 22 (0–40) 30 (0–45) 27 (0–43.5) 0.055
ICU survival (%) 63.0 62.1 62.5 0.899
Hospital survival (%) 63.0 62.1 62.5 0.899
All values represent means 6 SD unless otherwise specified.
1p-values based on the following tests: t-test for variables presented as means, Wilcoxon rank-sum test for variables presented as the median, Fisher’s exact test of
association for categorical variables.
doi:10.1371/journal.pone.0018166.t002
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and it is possible that they were instituted more readily in H1N1
patients. The risk of this confounding our interpretation is
mitigated by the use of a lung function outcome instead of vital
outcome or ventilator use, but still raises some caution. Finally, it is
unclear whether the same severity assessments would be true in
non-pandemic influenza. Further research is likely needed to
clarify this question and to determine whether this is related to
other more important patient-centered outcomes like mortality.
Conclusions
Despite our limitations, we believe this cohort study provides the
first description of co-interventions likely to influence severity of
lung injury in ARDS in H1N1 patients. The comparison of an
H1N1 cohort with a more relevant reference group of ARDS
patients, we feel ultimately makes the conclusions more robust
Figure 2. ARDS-related pulmonary measures over the first six days of treatment. All variables [A) PaO2/FiO2 ratio; B) positive end
expiratory pressure; C) pulmonary compliance; D) lung injury (Murray) score] are recorded from the first complete data point after 8am on each day of
observation while on conventional mechanical ventilation. Values from subjects requiring ECMO were dropped on days this modality was utilized.
Bars represent box plots for each variable by day and cause of ARDS (H1N1-associated vs non H1N1). Center line represents the median; edges of
each box represent the 75
th and 25
th percentiles and whiskers the maximum and minimum values. Dots indicate outliers. (n, for H1N1 associated
ARDS is 23, 20, 18, 17, 16 and 14 and non-H1N1 is 30, 33, 34, 30, 29 and 22 for day 0–5).
doi:10.1371/journal.pone.0018166.g002
Table 3. Unadjusted lung injury score by influenza status.
H1N1-associated
ARDS
Non H1N1-
associated ARDS P value
Day 0 LIS, table-2-
caption(mean ± SD)
3.2460.83 2.8460.45 0.019
AUC LIS/day of
observation,
(mean ± SD)
3.1760.69 2.7160.57 0.007
AUC, area under the curve for first daily lung injury scores.
doi:10.1371/journal.pone.0018166.t003
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this past year. It demonstrates that hypoxemia and lung injury in
patients with H1N1 is due specifically to the extent of respiratory
injury from the infection itself and not to secondary injury related
to the treatment of associated multi-organ failure. Whether this is
particular to H1N1 or generalized influenza associated ARDS is
unclear. This information may be of use in preparations for future
pandemics.
Acknowledgments
The authors acknowledge the unit staff who cared for these critically ill
patients, whose insights helped outline the questions addressed in this
manuscript.
Author Contributions
Conceived and designed the experiments: NAA MMS MCE BPR.
Performed the experiments: HCP TBA BPR. Analyzed the data: NAA
GSP MMS MCE. Wrote the paper: BPR NAA TBA HCP GSP MCE
MMS.
References
1. Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, et al. (2009) Critical care
services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med
361: 1925–1934.
2. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, et al. (2009) Critically
ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302:
1872–1879.
3. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L,
et al. (2009) Critically Ill patients with 2009 influenza A(H1N1) in Mexico.
JAMA 302: 1880–1887.
4. Jain S, Kamimoto L, Bramley A M, Schmitz AM, Benoit SR, et al. (2009)
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June
2009. N Engl J Med 361: 1935–1944.
5. Estenssoro E, Rios FG, Apezteguia C, Reina R, Neira J, et al. (2010) Pandemic
2009 influenza A in Argentina: a study of 337 patients on mechanical
ventilation. Am J Respir Crit Care Med 182: 41–48.
6. Davies A, Jones D, Bailey M, Beca J, Bellomo R, et al. (2009) Extracorporeal
Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory
Distress Syndrome. JAMA 302: 1888–1895.
7. Mitchell MD, Mikkelsen ME, Umscheid CA, Lee I, Fuchs BD, et al. (2010) A
systematic review to inform institutional decisions about the use of extracorpo-
real membrane oxygenation during the H1N1 influenza pandemic. Crit Care
Med 38: 1398–1404.
8. Miller RR, Markewitz BA, Rolfs RT, Brown SM, Dascomb KK, et al. (2010)
Clinical findings and demographic factors associated with ICU admission in
Utah due to novel 2009 influenza A(H1N1) infection. Chest 137: 752–758.
9. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, et al. (2010)
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the
United States. JAMA 303: 1517–1525.
10. McCallister JW, Adkins EJ, O’Brien JM, Jr. (2009) Obesity and acute lung
injury. Clin Chest Med 30: 495–508, viii.
11. O’Brien JM, Welsh CH, Fish RH, Ancukiewicz M, Kramer AM (2004) Excess
body weight is not independently associated with outcome in mechanically
ventilated patients with acute lung injury. Ann Intern Med 140: 338–345.
12. The National Heart, Lung and Blood Institute Acute Respiratory Distress
Syndrome ARDS Clinical Trials Network (2006) Comparison of Two Fluid-
Management Strategies in Acute Lung Injury. N Engl J Med 354: 2564–2575.
13. The National Heart, Lung and Blood Institute Acute Respiratory Distress
Syndrome ARDS Clinical Trials Network (2000) Ventilation with lower tidal
volumes as compared with traditional tidal volumes for acute lung injury and the
acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome
Network. N Engl J Med 342: 1301–1308.
14. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, et al. (2007) Transfusion-
related acute lung injury in the critically ill: prospective nested case-control
study. Am J Respir Crit Care Med 176: 886–891.
15. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, et al. (1994) The
American-European Consensus Conference on ARDS. Definitions, mecha-
nisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care
Med 149: 818–824.
16. Ginocchio CC, St George K (2009) Likelihood that an unsubtypeable influenza
A virus result obtained with the Luminex xTAG respiratory virus panel is
indicative of infection with novel A/H1N1 (swine-like) influenza virus. J Clin
Microbiol 47: 2347–2348.
17. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, et al. (2009) Efficacy
and economic assessment of conventional ventilatory support versus extracor-
poreal membrane oxygenation for severe adult respiratory failure (CESAR): a
multicentre randomised controlled trial. Lancet 374: 1351–1363.
18. Vincent JL (2006) Organ dysfunction in patients with severe sepsis. Surg Infect
(Larchmt) 7: S69–S72.
19. Kajdacsy-Balla Amaral AC, Andrade FM, Moreno R, Artigas A, Cantraine F,
et al. (2005) Use of the sequential organ failure assessment score as a severity
score. Intensive Care Med 31: 243–249.
20. Mauad T, Hajjar LA, Callegari GD, da Silva LF, Schout D, et al. (2010) Lung
pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit
Care Med 181: 72–79.
21. Gill JR, Sheng ZM, Ely SF, Guinee DG, Beasley MB, et al. (2010) Pulmonary
pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections.
Arch Pathol Lab Med 134: 235–243.
22. Lee N, Wong CK, Chan PK, Lun SW, Lui G, et al. (2007) Hypercytokinemia
and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe
human influenza A virus infection. Clin Infect Dis 45: 723–31.
23. Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, et al. (2010) Cytokine profiles
induced by the Novel swine-origin influenza A/H1N1 virus: Implications for
treatment strategies. J Infect Dis 201: 346–53.
24. The National Heart, Lung and Blood Institute Acute Respiratory Distress
Syndrome ARDS Clinical Trials Network (2006) Efficacy and Safety of
Corticosteroids for Persistent Acute Respiratory Distress Syndrome.
N Engl J Med 354: 1671–1684.
Table 4. Adjusted lung injury score by influenza status.
H1N1-associated ARDS Non H1N1-associated ARDS P value
LIS Mean 95% CI Mean 95% CI
Day 0 3.20 3.17–3.53 3.03 3.35–2.86 0.006
Day 1 3.16 3.15–3.49 3.00 3.32–2.84
Day 2 3.13 3.13–3.46 2.98 3.29–2.82
Day 3 3.11 3.10–3.43 2.95 3.27–2.79
Day 4 3.09 3.06–3.42 2.92 3.24–2.75
Day 5 3.08 3.02–3.40 2.90 3.21–2.71
AUC LIS 14.1 12.0–16.1 8.2 6.9–9.5 ,0.001
Analyses adjusted for significant covariates (change of risk factor coefficient by 615%) which included BMI, statin use and daily tidal volume used in addition to age and
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